1. Home
  2. CENTA vs VRDN Comparison

CENTA vs VRDN Comparison

Compare CENTA & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$37.84

Market Cap

2.3B

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$22.16

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENTA
VRDN
Founded
1955
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CENTA
VRDN
Price
$37.84
$22.16
Analyst Decision
Hold
Strong Buy
Analyst Count
4
14
Target Price
$36.75
$35.46
AVG Volume (30 Days)
275.8K
1.9M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.41
N/A
EPS
2.84
N/A
Revenue
$3,129,100,000.00
$5,706,000.00
Revenue This Year
$1.60
$13.73
Revenue Next Year
$2.04
$279.00
P/E Ratio
$13.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.97
$13.18
52 Week High
$40.80
$34.29

Technical Indicators

Market Signals
Indicator
CENTA
VRDN
Relative Strength Index (RSI) 47.24 62.73
Support Level $36.68 $17.97
Resistance Level $40.20 $34.18
Average True Range (ATR) 1.21 0.99
MACD -0.11 0.13
Stochastic Oscillator 23.25 67.40

Price Performance

Historical Comparison
CENTA
VRDN

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: